SER vs V · rev $56.0K vs P/E 33, rev $40.00B
Serina Therapeutics Inc (SER) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
SER currently screens at market cap $29.7M. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the SER and V stock pages for the full models.
Not investment advice.